Skip to main content

Table 1 Schedule of the study, with all detailed assessments for each study period

From: Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF)

  Study period
Enrollment Allocation Post-allocation Close- out
Timepoint** Interview Rand 1 M 6 M 12 M 24 M 36 M 48 M 60 M
Enrollment X         
Eligibility screen X         
Informed consent   X        
Allocation   X        
Angiograms   X        
History/events X X X X X X X X X
Anginal assessment X X X X X X X X X
Dyspnea assessment X X X X X X X X X
Medicines X X X X X X X X X
ECG X   X   X X X X X
Echocardiography X   X       X
Laboratory X     X X X X X
Interventions:
Surgery    X       
Angiograms          X
Assessments:
Follow-up    X X X X X X X
CT angiography          X
Neuropsychological Tests    X       X
ECG stress tests      X     X
Quality of life X    X X X X X X
Costs and effectiveness    X       X
Working status    X       X
  1. M month, ECG electrocardiogram. Laboratory tests will include creatinine, LDL-cholesterol, glycated hemoglobin, CK-MB, troponin, and BNP levels